Cognex (CGNX) Projected to Post Earnings on Wednesday

Key Points

• Cognex (CGNX) is projected to release its Q3 2025 earnings on October 29th, with analysts anticipating earnings of $0.27 per share and revenue of $261.861 million.
• The company recently declared a quarterly dividend of $0.08 per share, resulting in an annualized dividend of $0.32 and a yield of 0.7%.
• Cognex’s stock has received various ratings updates from analysts, with a consensus rating of "Moderate Buy" and an average target price of $44.93.

Cognex (NASDAQ:CGNX - Get Free Report) is projected to release its Q3 2025 results after the market closes on Wednesday, October 29th. Analysts expect Cognex to post earnings of $0.27 per share and revenue of $261.8610 million for the quarter. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS.Investors may visit the the company's upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Thursday, October 30, 2025 at 8:30 AM ET.

Cognex (NASDAQ:CGNX - Get Free Report) last announced its earnings results on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share for the quarter, topping analysts' consensus estimates of $0.23 by $0.02. Cognex had a net margin of 13.13% and a return on equity of 6.65%. The firm had revenue of $249.09 million during the quarter, compared to analyst estimates of $246.70 million. During the same period in the prior year, the business earned $0.23 EPS. The company's revenue for the quarter was up 4.2% compared to the same quarter last year. On average, analysts expect Cognex to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Cognex Price Performance

CGNX opened at $48.27 on Wednesday. The company has a market capitalization of $8.10 billion, a price-to-earnings ratio of 67.99 and a beta of 1.50. The business's 50-day moving average price is $44.88 and its two-hundred day moving average price is $35.76. Cognex has a 1 year low of $22.67 and a 1 year high of $49.76.

Cognex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Thursday, August 14th were given a dividend of $0.08 per share. The ex-dividend date of this dividend was Thursday, August 14th. This represents a $0.32 annualized dividend and a dividend yield of 0.7%. Cognex's payout ratio is 45.07%.

Analyst Ratings Changes

CGNX has been the subject of several recent analyst reports. Melius raised Cognex from a "hold" rating to a "buy" rating and set a $60.00 price objective for the company in a report on Thursday, July 10th. Weiss Ratings reiterated a "hold (c)" rating on shares of Cognex in a research note on Wednesday, October 8th. KeyCorp upgraded Cognex from a "sector weight" rating to an "overweight" rating and set a $50.00 price target for the company in a report on Friday, August 1st. DA Davidson lifted their price objective on shares of Cognex from $32.00 to $35.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. Finally, Citigroup restated a "neutral" rating and issued a $37.00 price target (up from $30.00) on shares of Cognex in a research note on Monday, July 14th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, Cognex currently has a consensus rating of "Moderate Buy" and an average target price of $44.93.

Insider Buying and Selling

In related news, EVP Sheila Marie Dipalma sold 2,002 shares of the company's stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $45.00, for a total transaction of $90,090.00. Following the completion of the sale, the executive vice president owned 8,582 shares of the company's stock, valued at $386,190. This represents a 18.92% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.60% of the stock is currently owned by company insiders.

Institutional Trading of Cognex

Institutional investors and hedge funds have recently made changes to their positions in the company. Geneos Wealth Management Inc. increased its stake in Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock valued at $27,000 after acquiring an additional 736 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its position in Cognex by 12.9% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,132 shares of the scientific and technical instruments company's stock worth $68,000 after purchasing an additional 243 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Cognex by 431.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,305 shares of the scientific and technical instruments company's stock valued at $73,000 after purchasing an additional 1,871 shares during the last quarter. FORA Capital LLC acquired a new stake in Cognex in the second quarter valued at approximately $232,000. Finally, Osaic Holdings Inc. grew its stake in shares of Cognex by 15.4% during the second quarter. Osaic Holdings Inc. now owns 8,352 shares of the scientific and technical instruments company's stock worth $264,000 after buying an additional 1,113 shares during the last quarter. Institutional investors own 88.12% of the company's stock.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.